Literature DB >> 10578173

Catalytic properties of the caspases.

H R Stennicke1, G S Salvesen.   

Abstract

Caspase stands for cysteine-dependent aspartate specific protease, and is a term coined to define proteases related to interleukin 1beta converting enzyme and CED-3.1 Thus their enzymatic properties are governed by a dominant specificity for substrates containing Asp, and by the use of a Cys side-chain for catalyzing peptide bond cleavage. The use of a Cys side chain as a nucleophile during peptide bond hydrolysis is common to several protease families. However, the primary specificity for Asp turns out to be very rare among protease families throughout biotic kingdoms. Of all known mammalian proteases only the caspase activator granzyme B, a serine protease, has the same primary specificity. In addition to this unusual primary specificity, caspases are remarkable in that certain of their zymogens have intrinsic proteolytic activity. This latter property is essential to trigger the proteolytic pathways that lead to apoptosis. Here we review the known enzymatic properties of the caspases and their zymogens within the broad context of structure:mechanism:activity relationships of proteases in general.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10578173     DOI: 10.1038/sj.cdd.4400599

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  35 in total

1.  Inhibition of distant caspase homologues by natural caspase inhibitors.

Authors:  S J Snipas; H R Stennicke; S Riedl; J Potempa; J Travis; A J Barrett; G S Salvesen
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Crystallizing ideas about Parkinson's disease.

Authors:  Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

Review 3.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

4.  Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Authors:  Lakshmi Venkatraman; Huipeng Li; C Forbes Dewey; Jacob K White; Sourav S Bhowmick; Hanry Yu; Lisa Tucker-Kellogg
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

5.  Response to bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores.

Authors:  Thomas Eissing; Steffen Waldherr; Frank Allgöwer; Peter Scheurich; Eric Bullinger
Journal:  Biophys J       Date:  2007-02-02       Impact factor: 4.033

6.  Molecular morphology of neuronal apoptosis: analysis of caspase 3 activation during postnatal development of mouse cerebellar cortex.

Authors:  Laura Lossi; Ilaria Tamagno; Adalberto Merighi
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

7.  A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen.

Authors:  Dennis Ma; Phillip Tremblay; Kevinjeet Mahngar; Pardis Akbari-Asl; Jonathan Collins; Tomas Hudlicky; James McNulty; Siyaram Pandey
Journal:  Invest New Drugs       Date:  2011-04-15       Impact factor: 3.850

Review 8.  The cysteine proteome.

Authors:  Young-Mi Go; Joshua D Chandler; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2015-04-03       Impact factor: 7.376

Review 9.  Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases.

Authors:  Jerzy Grabarek; Paul Amstad; Zbigniew Darzynkiewicz
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

10.  Phage display and structural studies reveal plasticity in substrate specificity of caspase-3a from zebrafish.

Authors:  Matthew B Tucker; Sarah H MacKenzie; Joseph J Maciag; Hayley Dirscherl Ackerman; Paul Swartz; Jeffrey A Yoder; Paul T Hamilton; A Clay Clark
Journal:  Protein Sci       Date:  2016-09-14       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.